Chicago Equity Partners’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-22,890
Closed -$639K 872
2019
Q4
$639K Sell
22,890
-21,660
-49% -$561K 0.04% 584
2019
Q3
$1.07M Buy
44,550
+24,820
+126% +$660K 0.05% 472
2019
Q2
$563K Buy
+19,730
New +$493K 0.03% 678

Other funds holding VCYT

Chicago Equity Partners's VCYT Position: Q1 2020 in Review

Chicago Equity Partners sold out of Veracyte (VCYT) in Q1 2020, closing a stake of 22,890 shares — an estimated $639K sold.

Chicago Equity Partners first reported a position in VCYT in Q2 2019 and held it in 3 quarters. The position peaked at $1.07M in Q3 2019. 165 funds tracked by Wall St. Rank hold VCYT as of Q1 2020.

  • Chicago Equity Partners reported no remaining Veracyte position as of Q1 2020 after selling out during the quarter.
  • Chicago Equity Partners sold 22,890 Veracyte shares in Q1 2020, an estimated $639K.
  • Chicago Equity Partners first reported a position in Veracyte in Q2 2019 and held it in 3 quarters.
  • Chicago Equity Partners's Veracyte position peaked at $1.07M in Q3 2019.
  • 165 funds tracked by Wall St. Rank held Veracyte as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.